从日本最新指南看心肌炎诊治的更新  

The update knowledge on myocarditis from the JCS 2023 Guideline for the Diagnosis and Treatment of Myocarditis

作　　者：袁璟[1,2,3] 龙琦 YUAN Jing;LONG Qi(Department of Cardiology,Union Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan,430022,China;Hubei Key Laboratory of Biological Targeted Therapy;Hubei Provincial Engineering Research Center of Immunological Diagnosis and Therapy for Cardiovascular Diseases)

机构地区：[1]华中科技大学同济医学院附属协和医院心内科,武汉430022 [2]生物靶向治疗研究湖北省重点实验室 [3]心血管疾病免疫诊疗湖北省工程研究中心

出　　处：《临床心血管病杂志》2024年第2期81-84,共4页Journal of Clinical Cardiology

基　　金：国家自然科学基金(No:81770378,81800333)。

摘　　要：日本循环学会于2023年3月发布了《2023JCS心肌炎诊断和治疗指南》,结合近年研究进展,对心肌炎分类、诊断、预后、治疗以及特殊类型心肌炎等内容进行更新。本文就2023JCS指南的部分要点进行提炼和解读,以期为我国临床医生管理心肌炎患者提供一定的实践指导。In March 2023,the Japanese Circulation Society(JCS)published the"JCS 2023Guideline on the diagnosis and treatment of myocarditis",which updates the classification,diagnosis,prognosis,treatment,and special types of myocarditis based on recent research progress.This article summarizes and interprets some key points of the 2023JCS guidelines,in order to provide practical guidance for clinicians in China to manage patients with myocarditis.

关 键 词：心肌炎 慢性炎症性心肌病 日本循环学会 JCS指南 

分 类 号：R542.2[医药卫生—心血管疾病]